Normal view MARC view ISBD view

Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences.

Singh, Awadhesh Kumar

Combination therapy of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: rationale and evidences. [electronic resource] - Expert review of clinical pharmacology 2016 - 229-40 p. digital

Publication Type: Journal Article; Review

ISSN: 1751-2441

Standard No.: 10.1586/17512433.2016.1123616 doi

Subjects--Topical Terms:
Animals
Diabetes Mellitus, Type 2--drug therapy
Dipeptidyl-Peptidase IV Inhibitors--administration & dosage
Drug Therapy, Combination
Glucose--metabolism
Humans
Hypoglycemic Agents--administration & dosage
Sodium-Glucose Transporter 2 Inhibitors

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)